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Abstract:	  20	  
Enteroviruses comprise a large group of mammalian pathogens that includes poliovirus. 21	  
Pathology in humans ranges from sub-clinical to acute flaccid paralysis, myocarditis and 22	  
meningitis. Until now, all the viral proteins were thought to derive from proteolytic processing of 23	  
a polyprotein encoded in a single open reading frame (ORF). We report that many enterovirus 24	  
genomes also harbor an upstream ORF (uORF) that is subject to strong purifying selection. 25	  
Using echovirus 7 and poliovirus 1, we confirmed expression of uORF protein (UP) in infected 26	  
cells. Using ribosome profiling (a technique for global footprinting of translating ribosomes), we 27	  
also demonstrated translation of the uORF in representative members of the predominant human 28	  
enterovirus species, namely Enterovirus A, B, and C. In differentiated human intestinal 29	  
organoids, UP-knockout echoviruses are attenuated compared to wild-type virus at late stages of 30	  
infection where membrane-associated UP facilitates virus release. Thus we have identified a 31	  
previously unknown enterovirus protein that facilitates virus growth in gut epithelial cells – the 32	  
site of initial viral invasion into susceptible hosts. These findings overturn the 50-year-old dogma 33	  
that enteroviruses use a single-polyprotein gene expression strategy, and have important 34	  
implications for understanding enterovirus pathogenesis. 35	  
 36	  
Main	  Text:	   	  37	  
Enteroviruses are ubiquitous worldwide, highly infectious and environmentally stable. While 38	  
many infections are mild or asymptomatic, some serotypes can cause severe and even fatal 39	  
disease with symptoms ranging through fever, hand foot and mouth disease, myocarditis, viral 40	  
meningitis, encephalitis, acute hemorrhagic conjunctivitis, and acute flaccid paralysis. Although 41	  
the enterovirus that causes poliomyelitis has been eradicated from much of the globe, other 42	  
emerging enteroviruses can cause severe polio-like symptoms 1. The Enterovirus genus belongs 43	  
to the Picornaviridae family. Members have monopartite linear positive-sense single-stranded 44	  
RNA genomes of ~7.4 kb, that are encapsidated into non-enveloped icosahedral virions. 45	  
Currently, 13 species (Enterovirus A-J and Rhinovirus A-C) and more than 70 serotypes have 46	  
been defined. The virus genome contains a single long open reading frame (ORF) which is 47	  
translated as a large polyprotein that is cleaved to produce the viral capsid and nonstructural 48	  
proteins 2 (Fig. 1a). The 3ʹ end of the genome is polyadenylated and contains signals involved in 49	  
replication and genome circularization. The 5ʹ end is covalently bound to a viral protein, VPg, 50	  
and the 5ʹ UTR harbors an internal ribosome entry site (IRES) that mediates cap-independent 51	  
translation. 52	  
 53	  
The enterovirus IRES comprises several structured RNA domains denoted II to VI (Fig. 1a). 54	  
Ribosome recruitment requires eukaryotic initiation factors eIF2, eIF3, eIF4A, eIF4G, eIF4B and 55	  
eIF1A but not the cap-binding protein eIF4E 3. Domain VI (dVI) comprises a stem-loop 56	  
containing a highly conserved AUG codon (586AUG in poliovirus) in a poor initiation context. 57	  
The dVI AUG plays an important role in stimulating attachment of 43S ribosomal preinitiation 58	  
complexes to the viral mRNA, which then scan or otherwise migrate to the polyprotein initiation 59	  
site downstream (743AUG in poliovirus) 4–6. In poliovirus type 1 (PV1), the dVI AUG is followed 60	  
by a 65-codon upstream ORF (uORF) that overlaps the polyprotein ORF (ppORF) by 38 nt, and 61	  
some other enteroviruses contain a similarly positioned uORF 3,7. However, multiple previous 62	  
studies have indicated that the dVI AUG is not itself utilized for initiation 6–8, and the 6.5–9.0 63	  
kDa protein that might result from uORF translation has never been detected in enterovirus-64	  
infected cells. The “spacer” sequence between dVI and the polyprotein AUG contains little 65	  
obvious RNA structure and indeed is not particularly well-conserved at the nucleotide level. 66	  
Despite three decades of research, its function remains unknown. 67	  
 68	  
Here we performed a comparative analysis of >3000 enterovirus sequences, from which we show 69	  
that the uORF is largely conserved in major enterovirus groups and the encoded amino acids are 70	  
subject to strong purifying selection indicating that it encodes a functional protein. We used 71	  
ribosome profiling to demonstrate translation of the uORF in three enterovirus species. 72	  
Moreover, we show that knocking out expression of the uORF protein (termed UP) significantly 73	  
attenuates virus growth in differentiated mucosa-derived human intestinal organoids but not in 74	  
standard cell culture systems, suggesting a specific role for UP during establishment of 75	  
productive virus infection in gut epithelia in the initial stages of virus invasion of susceptible 76	  
hosts. 77	  
 78	  
We obtained all full-length enterovirus sequences from GenBank, clustered these into species, 79	  
and identified the dVI AUG in each. Sequences were defined as having the uORF if the ORF 80	  
beginning with this AUG codon overlaps the 5ʹ end of the ppORF and contains at least 150 nt 81	  
upstream of the polyprotein AUG codon. The majority of Enterovirus A, B, E, F and G 82	  
sequences and around half of Enterovirus C sequences contain an intact uORF (Fig. 1b). In 83	  
contrast, the uORF is absent from Rhinovirus A, B and C, and Enterovirus D sequences. Clades 84	  
without the uORF, particularly the rhinoviruses, tend to have a much shorter spacer between the 85	  
dVI AUG and the polyprotein AUG (Fig. 1c). Although Enterovirus D sequences have a mid-86	  
sized spacer (Fig. 1c), the dVI AUG-initiated ORF has just 5 codons in 437 of 442 sequences, 87	  
and there is no alternative uORF beginning at a different site. Translation of the uORF, where 88	  
present, in Enterovirus A, B, C, E, F and G would produce a peptide of 56–76 amino acids, 6.5–89	  
9.0 kDa, and pI 8.5–11.2 (median values by group; Table S1; Fig. S1a). The 3ʹ quarter of the 90	  
uORF overlaps the ppORF in either the +1 or +2 frame (Table S1) leading to differing C-91	  
terminal tails in UP. 92	  
 93	  
Although the uORF is not present in all sequences, we wished to ascertain whether, where 94	  
present, it is subject to purifying selection at the amino acid level. To test this we used MLOGD 9 95	  
and codeml 10. Codeml measures the ratio of non-synonymous to synonymous substitutions 96	  
(dN/dS) across a phylogenetic tree; dN/dS < 1 indicates selection against non-synonymous 97	  
substitutions, which is a strong indicator that a sequence encodes a functional protein. 98	  
Application of codeml to within-species uORF alignments (excluding the overlap region) 99	  
resulted in dN/dS estimates in the range 0.04 to 0.22 for Enterovirus A, B, C, E, F and G (Table 100	  
S1). MLOGD uses a principle similar to dN/dS but also accounts for conservative amino acid 101	  
substitutions (i.e. similar physico-chemical properties) being more probable than non-102	  
conservative substitutions in biologically functional polypeptides. MLOGD 3-frame “sliding 103	  
window” analysis of full-genome alignments revealed a strong coding signature in the ppORF 104	  
(as expected) and also in the uORF, with this result being replicated independently for each of 105	  
the six enterovirus species (Fig. 1d and Fig. S1b). 106	  
 107	  
To evaluate the significance of UP in virus infection, we first utilized an infectious clone of 108	  
echovirus 7 (EV7), a member of the species Enterovirus B. In EV7, the predicted UP protein is 109	  
8.0 kDa, has a pI of 10.5, and a predicted transmembrane (TM) domain (Fig. 2a).  A set of 110	  
mutant virus genomes was created and tested for RNA infectivity, virus titer, plaque size, 111	  
stability of the introduced mutations, competitive growth with wild-type (wt) virus, and relative 112	  
IRES activity in a dual luciferase reporter system. Mutants with premature termination codons 113	  
(PTC) introduced at uORF codons 5 or 29 (EV7-Loop and EV7-PTC, respectively; Fig. 2b and 114	  
Fig. S2a) behaved similarly to wt EV7 in all tested assays (Fig. 2c-d and Fig. S3a), indicating 115	  
that UP is not required in the context of the susceptible RD cell line. 116	  
 117	  
Consistent with previously published poliovirus data 4,7, mutating the EV7 dVI AUG (591AUG) 118	  
to AAG with a compensatory 615A-to-U mutation to maintain the stem-loop base-pairing (EV7-119	  
mAUG; Fig. 2b and Fig. S2a) resulted in a substantial drop in IRES activity to 15% of wt (Fig. 120	  
2d). This drop in IRES activity likely explains the attenuated virus growth followed by 100% 121	  
reversion occurring after the second passage in RD cells (Fig. 2c). Consequently the EV7-122	  
mAUG mutant was not used for further uORF studies. 123	  
 124	  
We next sought to determine whether UP is expressed during virus infection. To facilitate this, a 125	  
version of EV7 designed to produce C-terminally Strep-tagged UP and a corresponding PTC 126	  
control (EV7-StrUP and EV7-StrUP-PTC; Fig. 2b and Fig. S2b) were created. IRES activity 127	  
dropped to 80% wt for both EV7-StrUP and EV7-StrUP-PTC (Fig. 2d); nevertheless, this did not 128	  
noticeably affect the RNA infectivities, virus titers, plaque size, or stability of the introduced 129	  
mutations (Fig. 2c). We then infected RD cells at high multiplicity of infection (MOI) with wt or 130	  
mutant viruses and analyzed cell lysates by immunoblotting. A protein migrating at the expected 131	  
size was detected in 6 and 8 h post infection (hpi) lysates from cells infected with EV7 or EV7-132	  
StrUP viruses (with anti-UP and anti-Strep antibodies, respectively), but not for cells infected 133	  
with the PTC mutants, thus confirming expression of UP (Fig. 3a-b, upper panels). Further 134	  
analyses confirmed that the introduced mutations did not affect virus structural protein 135	  
accumulation (Fig. 3a-b, lower panels; Fig. S11a), or virus growth kinetics in one-step growth 136	  
curves in RD cells (Fig. 3c). 137	  
 138	  
To further study virus gene expression, we infected RD cells with wt EV7 and performed 139	  
ribosome profiling (Ribo-Seq) at 4 and 6 hpi. Ribosome profiling maps the footprints of actively 140	  
translating 80S ribosomes but not scanning or preinitiation ribosomes. Ribo-Seq quality was 141	  
assessed as previously described (Fig. S4) 11. For these libraries, ribosome protected fragment 142	  
(RPF) 5ʹ ends mapped predominantly to the first nucleotide positions of codons (phase 0) (Fig. 143	  
S4c), thus allowing robust identification of the reading frame in which translation is taking place. 144	  
Within the ppORF, RPFs mapped predominantly to the first nucleotide positions of polyprotein 145	  
codons (blue phase). However, within the non-overlapping portion of the uORF, RPFs mapped 146	  
predominantly to the first nucleotide positions of uORF codons (green phase) (Fig. 3d and Fig. 147	  
S4d) confirming uORF translation. Ribosome density in the uORF was comparable to ribosome 148	  
density in the ppORF (Fig. 3d-e). With our Ribo-Seq protocol, a peak in RPF density is 149	  
frequently observed on initiation sites (Fig. S4a). Consistently, the first peak in the green phase 150	  
mapped precisely to the dVI AUG codon (Fig. 3d and Fig. S4d). 151	  
 152	  
To confirm translation of UP in other enteroviruses we performed ribosome profiling with PV1 153	  
and EV-A71, members of the species Enterovirus C and A, respectively. PV1 is a causative agent 154	  
of poliomyelitis whereas EV-A71 is one of the major causative agents of hand, foot and mouth 155	  
disease. Both viruses have the potential to cause severe neurological disease. For both PV1 and 156	  
EV-A71, the uORF initiation site within the 5ʹ RNA structure and the UP protein properties are 157	  
similar to those of EV7 (Fig. 4a and 4e). The predicted UP is 7.2 kDa with a pI of 9.2 in PV1 and 158	  
8.8 kDa with a pI of 9.5 in EV-A71, and both UPs have a predicted TM domain.  159	  
 160	  
The PV1 growth characteristics were found to be similar to those of EV7 – reaching complete 161	  
cytopathic effect at 7–8 hpi at high MOI. On the other hand, EV-A71 growth was slower with 162	  
complete cytopathic effect at 10–11 hpi. Consistently, VP3 accumulation in infected cells was 163	  
fastest in PV1 (4 hpi), followed by EV7 (6 hpi), and slowest in EV-A71 (8 hpi) (Fig. 4f). Hence, 164	  
for PV1 we used ribosome profiling time points 4 and 6 hpi whereas for EV-A71 we used 5 and 165	  
7.5 hpi. Ribo-Seq data quality was assessed as before (Fig. S5 and Fig. S6). In PV1 the uORF is 166	  
in the +2 frame relative to the ppORF and, once again, within the non-overlapping portion of the 167	  
uORF RPFs mapped predominantly to the first nucleotide positions of uORF codons (orange 168	  
phase) (Fig. 4b and Fig. S5d). Similarly to EV7, the PV1 uORF was found to be efficiently 169	  
translated (Fig. 4b-c) and the first peak in the orange phase mapped precisely to the dVI AUG 170	  
codon (Fig. 4b and Fig. S5d). For EV-A71, the uORF is also in the +2 frame relative to the 171	  
ppORF. RPF density in the uORF phase (orange) was substantially lower for EV-A71 than for 172	  
EV7 and PV1 (Fig. 4g-h and Fig. S6d). Nonetheless, the first peak in the orange phase mapped 173	  
precisely to the dVI AUG codon (Fig. 4g and Fig. S6d) indicating that the uORF is also 174	  
translated in EV-A71, but probably at lower efficiency than in EV7 and PV1. 175	  
 176	  
Following the strategy used for EV7, we designed a version of PV1 to produce C-terminally HA-177	  
tagged UP, and corresponding PTC and Loop mutant controls (PV1-HA, PV1-HA-PTC and 178	  
PV1-HA-Loop; Fig. S7a). Tagging resulted in moderate attenuation (Fig. S7b). A protein 179	  
migrating at the expected size was detected in 11 hpi lysates from RD cells infected with PV1-180	  
HA, but not for cells infected with wt PV1 or the PTC or Loop mutants, thus confirming 181	  
expression of UP during virus infection (Fig. 4d, upper panels). There were no major differences 182	  
in accumulation of virus structural proteins between the different viruses (Fig. 4d, lower panels; 183	  
Fig. S11c). 184	  
 185	  
We next investigated possible effects of UP during infection in other cell lines and experimental 186	  
conditions. Initial tests found no difference between wt and PTC mutants in any permissive cell 187	  
line tested (MA104, HEK293T, HeLa, CaCo2, Huh7, HGT) at any MOI, even upon induction of 188	  
an antiviral state by interferon treatment. Working with a mouse-pathogenic poliovirus mutant, 189	  
Mah(L), an earlier analysis by Slobodskaya and colleagues found that a 103-nt deletion in the 5ʹ 190	  
UTR (∆S mutant) – that truncates the uORF to 31 codons and fuses it in-frame with the ppORF – 191	  
resulted in no attenuation; in contrast, mutation of the dVI AUG abrogated neurovirulence, 192	  
presumably due to its effect on IRES activity 12. Thus we hypothesised that UP might instead 193	  
play a role at the primary site of infection, namely the gastrointestinal tract, which for many 194	  
enteroviruses is the critical site of virus amplification before dissemination and further 195	  
progression of systemic infection 13. 196	  
 197	  
The mouse model for enterovirus infection has several limitations: (i) a requirement for 198	  
substantial virus adaptation, and immunodeficient or receptor-transgenic mouse strains, (ii) 199	  
mouse models do not closely mimic human disease, and (iii) although a good model for 200	  
neurovirulence studies, low sensitivity of the mouse alimentary tract to enterovirus precludes 201	  
examination of the enteric stage of virus replication. Thus, to address a role for UP in the 202	  
gastrointestinal tract, we utilized a recently developed human intestinal epithelial organoid 203	  
platform to examine possible effects of UP in differentiated organoids 14. We generated 3-204	  
dimensional organoids derived from distal small bowel (i.e. terminal ileum) mucosal biopsies of 205	  
patients. Following establishment of cultures, organoids were trypsinized and grown to form 206	  
differentiated monolayers. Differentiation into epithelial cell subsets, predominantly consisting 207	  
of absorptive enterocytes, was achieved by withdrawal of wnt agonists as previously described 208	  
15,16 (Fig. 5a) and tested by qRT-PCR (Fig. S8). Monolayers were then infected with wt or 209	  
mutant viruses. At late time points we observed a 75–90% reduction in EV7-Loop or EV7-PTC 210	  
titers compared to wt EV7 titers (p = 4.6 × 10−5 and 5.5 × 10−5 at 36 and 48 hpi when combined 211	  
over the two patients; Fig. 5b). For EV7, EV7-Loop and EV7-PTC viruses, the initial infection 212	  
(6–9 hpi) was restricted to 5–20% of the organoid monolayer (Fig. 5c), which later progressed to 213	  
complete cytopathic effect by 24–48 hpi (Fig. 5d).  214	  
 215	  
To investigate the cause of the growth defect of UP mutants in differentiated human intestinal 216	  
organoids, we first quantified viral protein and viral RNA in the 36 and 48 hpi samples. 217	  
However, even after normalizing by protein or RNA, UP mutant titers were still below wt titers 218	  
[mean fold difference = 0.24; p = 0.00022, 0.000017 (titer/protein) and 0.00016, 0.000016 219	  
(titer/RNA) at 36 and 48 hpi when combined over patients; Fig. 5e]. Since UP contains a 220	  
predicted TM region, we hypothesized that it may play a role in virus release from membranes. 221	  
Therefore, we subjected the same samples to Triton X-100 detergent treatment (Fig. 5f). This 222	  
had little effect on wt titers (mean fold increase = 1.2) but increased UP mutant titers (mean fold 223	  
increase = 2.4) with the change in mutant titers being significantly different from the change in 224	  
wt titers (p = 0.00087 and 0.000056 at 36 and 48 hpi when combined over patients; Fig. 5f). The 225	  
lysed cells from 48 hpi were also tested for Triton X-100 mediated virus release. Consistently, 226	  
the change in mutant titers (mean fold increase = 5.2) was significantly different from the change 227	  
in wt titers (mean fold increase = 2.0) (p = 0.000086 when combined over patients; Fig. 5g). 228	  
 229	  
To further test our hypothesis that UP facilitates disruption of organoid-derived membranes, we 230	  
performed membrane flotation assays for virus-containing media derived from infected 231	  
differentiated organoid cultures. At 36 hpi, the ratio of membrane-bound to free virus for the 232	  
EV7-PTC and EV7-Loop mutants exceeded that for wt EV7 by a mean of 3.1 fold (p = 0.026; 233	  
two-tailed t-test, comparing patient 1 and 2 wt against the four mutant samples; Fig. 5h). In 234	  
contrast, no membrane-associated virus was detected when the assay was repeated for RD cell-235	  
derived EV7 (Fig. 5h, green curve), explaining why no difference between wt and UP-knockout 236	  
virus titers was observed for these cells. We also compared neutralization of organoid-derived 237	  
membrane fractions and RD cell-derived virus by treating with EV7 neutralization serum and/or 238	  
via prevention of receptor-mediated attachment using anti-DAF antibody 17. The flotated 239	  
membrane fractions were only partially neutralized in all three assays, whereas neutralization of 240	  
RD cell-derived virus was significantly more efficient (Fig. 6a). Additionally, for RD cell-241	  
derived virus the neutralization serum and anti-DAF antibody acted synergistically (p = 0.0004 242	  
and 0.0007 for each independent treatment compared to the combined treatment; two-tailed t-243	  
tests; Fig. 6a). However, this was not the case for the flotated membrane fractions (Fig. 6a), 244	  
suggesting that non-neutralized membrane-associated virus enters cells by a route not involving 245	  
receptor binding – for example via membrane fusion. Taken together, these results suggest that 246	  
UP plays a role in release of virus particles from membranous components. 247	  
 248	  
Since detectable accumulation of UP in infected cells coincides with strong cytopathic effect that 249	  
leads to autofluorescence, we studied the subcellular localization of UP in transfected HeLa cells 250	  
as well as in a stably expressing HeLa cell line. This revealed an endoplasmic reticulum (ER)-251	  
associated pattern confirmed by co-staining with calnexin, an ER marker (Fig. 6b and Fig. S9). 252	  
We also confirmed membrane association of UP by subcellular fractionation of UP-expressing 253	  
HeLa cells and subsequent analysis of the fractions (Fig. 6c). 254	  
 255	  
As a result of variations in translational speed (including pausing, and potential stacking behind 256	  
ribosomes initiating at the polyprotein AUG), besides nuclease, ligation and PCR biases 257	  
introduced during library preparation, ribosome profiling may not provide an accurate estimation 258	  
of protein expression levels, particularly for short ORFs 11. Therefore, to investigate the relative 259	  
level of uORF expression, we used dual-luciferase reporter constructs where the 2A-FFLuc 260	  
cassette was placed either in the uORF or ppORF reading frame just downstream of the ppORF 261	  
initiation codon (Fig. 6d). HeLa cells were transfected with the reporter construct with or without 262	  
co-transfection of T7-transcribed infectious EV7 RNA. The ratio of uORF to ppORF expression 263	  
did not change greatly over time and, consistent with the poor initiation context of the uORF, 264	  
ppORF translation was 19–23 times more efficient than uORF translation in the context of virus 265	  
infection (Fig. 6e). Encoding of UP in a separate ORF may be a strategy to allow expression of 266	  
UP at a level very different from that of the polyprotein products. As expected, IRES activity 267	  
(both in the uORF and ppORF reading frames) increased relative to cap-dependent translation as 268	  
infection progressed (Fig. 6f). 269	  
 270	  
To test whether other members of the family Picornaviridae might also harbor undiscovered 271	  
proteins encoded by alternative ORFs, we applied our comparative genomic methods to other 272	  
picornaviruses, revealing putative additional protein-coding ORFs in ten Picornaviridae clades 273	  
(Fig. S13-S21). 274	  
 275	  
The data presented here demonstrate the existence of an additional protein, UP, encoded by the 276	  
enterovirus genome. The molecular biology of enteroviruses has been studied for over 50 years, 277	  
not least because poliovirus is such an important pathogen 18. Even before the poliovirus genome 278	  
was first sequenced in 1981 19,20, all viral polypeptides were presumed to derive from the single 279	  
polyprotein 21. The uORF product was likely overlooked due to its small size and low expression 280	  
level. On the other hand, the function of the apparent “spacer” region between the IRES and the 281	  
polyprotein initiation site was perplexing, particularly since it is absent in rhinoviruses. 282	  
 283	  
Our analysis now demonstrates that, at least in EV7 (Enterovirus B), this region encodes a small 284	  
protein, UP, that is not required for basic replication but plays an important role in virus growth 285	  
in gut epithelial cells, the site of initial viral invasion into a susceptible host. Ribosome profiling 286	  
revealed uORF translation in three enterovirus species and UP expression in EV7 and PV1 was 287	  
further confirmed by western blot. Comparative genomic analysis shows that the uORF is 288	  
predominantly present in Enterovirus A, B, E, F and G and around half of Enterovirus C isolates 289	  
and, where present, is subject to strong purifying selection. In contrast, the uORF is ubiquitously 290	  
absent from rhinoviruses which infect the upper respiratory tract instead of the gastrointestinal 291	  
tract, consistent with UP playing a specific role in gut epithelial cells. At least some 292	  
enteroviruses that lack UP have in fact been shown to be respiratory viruses 22. It is possible that, 293	  
in enteric viruses which lack UP, its function may be taken over by another membrane-294	  
associated protein such as the viroporin 2B; alternatively it may simply be that their replication 295	  
or tropism is such that a UP function is not required. Interestingly, the majority of poliovirus type 296	  
2 and 3 sequences have only a truncated uORF (mode lengths 38 and 18 codons, respectively), 297	  
too short to meet our definition of uORF presence. However, most available sequences (203/229) 298	  
of poliovirus type 1 – the most common serotype – have an intact uORF. 299	  
 300	  
Previous cell-free translation studies had indicated that the dVI AUG was not, or only weakly, 301	  
utilized as an initiation site in wt PV1, though it can be “activated” if its initiation context is 302	  
artificially enhanced 7,23. Using an in vitro reconstituted translation system, only trace amounts of 303	  
48S complexes were observed to form at the PV1 dVI AUG, and the EV-A71 dVI AUG was not 304	  
recognized 3. Interestingly, much higher levels of 48S initiation complex formation were 305	  
observed at the uORF AUG in bovine enterovirus (Enterovirus E) where the dVI stem-loop is 306	  
less stable. In the context of a cell-free translation system, the same authors found detectable but 307	  
very inefficient 80S ribosomal complex formation at the PV1 dVI AUG and even lower amounts 308	  
at the EV-A71 dVI AUG 3,24. Ribo-Seq analysis allowed us to study ribosome occupancy 309	  
throughout the 5ʹ UTR, in a cellular context, and in the context of virus infection. In contrast to 310	  
much of the previous in vitro work, this revealed efficient translation of the uORF in EV7 and 311	  
PV1, and a low level of translation in EV-A71. 312	  
 313	  
While non-enveloped viruses have traditionally been assumed to exit cells via cell lysis, there is 314	  
increasing recognition of non-lytic release pathways of either free or membrane-bound virus 315	  
particles 25–27. The late stage of the UP-knockout defect, however, suggests that it is not related 316	  
to non-lytic release. Enteroviruses also subvert the host autophagy pathway – leading to 317	  
intracellular double- or single-membraned virus-containing vesicles – and can be released from 318	  
cells in various membrane-bound forms 26–28. The intriguing drop in UP-knockout virus titers 319	  
observed at late stages of organoid infections, their rescue upon detergent treatment, and the 320	  
increased proportion of membrane-associated virus in the absence of UP, suggests the 321	  
importance of UP as a membrane disruptor to facilitate virus particle release from vesicles 322	  
peculiar to gut epithelial cell infection. 323	  
 324	  
These data overturn the long-established dogma of a single-polyprotein gene expression strategy 325	  
in the enteroviruses, and open a new window on our understanding of enterovirus molecular 326	  
biology and pathogenesis. An increased understanding of the precise role(s) of UP in different 327	  
enterovirus species, and the differences between Enterovirus C isolates that contain or lack an 328	  
intact uORF, may lead to new virus control strategies; indeed UP knockout mutants may have 329	  
applications as attenuated virus vaccines. 330	  
  331	  
Materials	  and	  methods	  332	  
 333	  
Cells and viruses 334	  
RD cells (human rhabdomyosarcoma cell line, ATCC, CCL-136), HEK293T cells (human 335	  
embryonic kidney cell line, ATCC, CRL-3216) and HeLa cells (ATCC, CCL-2) were maintained 336	  
at 37 ºC in DMEM supplemented with 10% fetal bovine serum (FBS), 1 mM L-glutamine, and 337	  
antibiotics. All cells were mycoplasma tested and authenticated by deep sequencing. 338	  
 339	  
The cDNA of Echovirus 7 strain Wallace was sourced from Michael Lindberg (GenBank 340	  
accession number AF465516, with silent substitution 1687G-to-A), and was cloned downstream of 341	  
a T7 RNA promoter. The cDNA of wt PV1 (strain Mahoney, GenBank accession number 342	  
V01149.1, with substitutions 2133C-to-T and 2983A-to-G) was sourced from Bert Semler, 343	  
University of California, and was cloned downstream of a T7 RNA promoter with a hammerhead 344	  
ribozyme at the 5′ end as previously described 29. Enterovirus EV-A71 strain B2 MS/7423/87 345	  
(GenBank accession number MG432108) was plaque-purified using RD cells, sequenced, 346	  
titrated on RD cells and used for ribosome profiling infections. EV7, PV1 and mutant viruses 347	  
were rescued via transfection of RD cells with T7-transcribed RNAs using Lipofectamine® 2000 348	  
(Invitrogen). RNA infectivity was assessed by infectious center assay where RD monolayers 349	  
were overlaid with dilutions of a suspension of RNA-transfected RD cells, incubated for 3 h, 350	  
overlaid with 1.5% low melting point agarose (catalog number 16520-100; Invitrogen) in 351	  
DMEM containing 1% FBS, and incubated for 48 h at 37 °C until the formation of plaques. 352	  
Alternatively, to collect recovered viruses, the transfection medium was replaced with DMEM 353	  
containing 1% FBS and incubation was continued for 20 h until the appearance of 100% 354	  
cytopathic effect. Virus stocks were amplified on RD cells, cleared by centrifugation, purified 355	  
through a 0.22 µm filter, titrated on RD cells and used for subsequent infections. All mutant 356	  
viruses were also passaged at least 3 times at low MOI (0.01–0.1). The final virus stocks were 357	  
used for RNA isolation and RT-PCR analysis to confirm the presence or reversion of the 358	  
introduced mutations. 359	  
 360	  
Plasmids 361	  
For mammalian expression of UP, the coding sequence of EV7 UP, EV7 UP with C-terminal 362	  
Strep-tag, or PV1 UP with C-terminal HA-tag was inserted in vector pCAG-PM 30 using AflII 363	  
and PacI restriction sites. The resulting constructs designated pCAG-UP, pCAG-StrUP, and 364	  
pCAG-HA-UP, respectively, were confirmed by sequencing.  365	  
 366	  
All EV7 (Fig. S2) and PV1 (Fig. S7) mutations were introduced using site-directed mutagenesis 367	  
of the pT7-EV7 or pT7-PV1 infectious clone, respectively, and confirmed by sequencing. For 368	  
Strep-tagged EV7 and HA-tagged PV1, the uORF/ppORF overlap was duplicated and 369	  
synonymously mutated to avoid recombination (see Fig. S2b and Fig. S7a, respectively, for 370	  
details). The resulting plasmids were linearized with XhoI (EV7) or EcoRI (PV1) prior to T7 371	  
RNA transcription.  372	  
 373	  
For assessing relative IRES activity in a reporter system, the pSGDLuc vector was used to design 374	  
a cassette having a cap-dependent Renilla luciferase gene followed by 748 nucleotides of 5ʹ-375	  
terminal EV7 sequence (entire 5ʹ UTR and first 2 ppORF codons) fused in frame with the 2A 376	  
firefly luciferase gene 31. To assess IRES activity in the uORF reading frame, the 2A firefly 377	  
luciferase gene was fused after the 7th nucleotide of the ppORF. The resulting plasmids were 378	  
linearized with BamHI prior to T7 RNA transcription. 379	  
 380	  
RNA transcript preparation 381	  
Transcription reactions were performed with T7 RNA polymerase MEGAscript T7 transcription 382	  
kit (Ambion). Ten microliter transcription reactions were incubated for 1 h at 37 °C and 383	  
terminated by treatment with DNase I for 15 min at 37 °C. 384	  
 385	  
Reporter assay for relative IRES activity 386	  
HEK293T cells were transfected in triplicate with Lipofectamine 2000 reagent (Invitrogen), 387	  
using the protocol in which suspended cells are added directly to the RNA complexes in 96-well 388	  
plates. For each transfection, 100 ng of purified T7 RNA (RNA Clean and Concentrator, Zymo 389	  
research) plus 0.3 µL Lipofectamine 2000 in 20 µL Opti-Mem (Gibco) supplemented with 390	  
RNaseOUTTM (Invitrogen; 1:1,000 diluted in Opti-Mem) were added to each well containing 105 391	  
cells. Transfected cells in DMEM supplemented with 5% FBS were incubated at 37 °C for 16 h. 392	  
Firefly and Renilla luciferase activities were determined using the Dual Luciferase Stop & Glo 393	  
Reporter Assay System (Promega). IRES activity was calculated as the ratio of Firefly (IRES-394	  
dependent translation) to Renilla (cap-dependent translation), normalized by the same ratio for 395	  
wt EV7 sequence. Three independent experiments were performed to confirm the reproducibility 396	  
of the results. For temporal analysis of the ppORF:uORF expression ratio, a similar protocol was 397	  
used but with HeLa cells to support EV7 replication. EV7 infection was achieved by co-398	  
transfection of capped T7 EV7 RNA (150 ng per transfection), and the released virus was titrated 399	  
by plaque assay on RD cells. 400	  
 401	  
Virus competition assay 402	  
Dual infection/competition assays were performed in duplicate on RD cells using mutant and wt 403	  
EV7 at either equal or 9:1 proportions at total MOI 0.1. Mono-infections by wt or mutant viruses 404	  
were used as controls. Media collected from infected plates was used for 5 blind passages using 405	  
1:10,000 volume of obtained virus stock (corresponds to MOI 0.05–0.2). RNA was isolated from 406	  
passages 1 and 5 using Direct-zol™ RNA MicroPrep (Zymo research) and used for RT-PCR and 407	  
Sanger sequencing of the fragment containing the mutated region of the virus genome. The final 408	  
chromatograms were compared and evaluated based on three RT-PCR products from each 409	  
analyzed sample (Fig. S3b). 410	  
 411	  
SDS-PAGE and immunoblotting 412	  
Lysates from virus-infected or pCAG-transfected cells were analyzed by SDS-PAGE, using 413	  
standard 12% SDS-PAGE to resolve virus structural proteins and precast Novex™ 10–20% 414	  
tricine protein gels (Thermo fisher) to resolve UP. Proteins were then transferred to 0.2 µm 415	  
nitrocellulose membranes and blocked with 4% Marvel milk powder in phosphate-buffered 416	  
saline (PBS). Immunoblotting of the enterovirus VP3 structural protein was performed using 417	  
Enterovirus pan monoclonal antibody (Thermo Fisher, MA5-18206) at 1:1,000 dilution. A 418	  
custom rabbit polyclonal antibody raised against C-terminal UP peptide CPPRKPEPMRLG 419	  
(GenScript), an anti-Strep mouse antibody (Abcam, ab184224), and an anti-HA mouse antibody 420	  
(Abcam, ab130275) were used for detection of EV7 UP, EV7 Strep-tagged UP, and PV1 HA-421	  
tagged UP, respectively. The following antibodies were used for cellular targets: anti-tubulin 422	  
(Abcam, ab15568), anti-VDAC1 (Abcam, ab14734), anti-GAPDH (Ambio, AM4300) and anti-423	  
calnexin (Merck, MAB3126). To ensure synchronicity of infection, a high MOI was used for 424	  
virus infections. Immunoblots were imaged and analyzed on a LI-COR imager. The original 425	  
LICOR scans and quantifications are shown in Fig. S11.  426	  
 427	  
Sampling, preparation and infection of human intestinal organoid monolayers 428	  
Following ethical approval (REC-12/EE/0482) and informed consent, intestinal biopsies were 429	  
collected from the terminal ileum of patients undergoing routine endoscopy. All patients 430	  
included had macroscopically and histologically normal mucosa. Biopsy samples were processed 431	  
immediately and intestinal epithelial organoids generated from isolated crypts following an 432	  
established previously described protocol 15,16. 433	  
 434	  
To form differentiated monolayers for infection, 48-well plates or IBIDI 8-well chamber slides 435	  
were collagen-coated 2 h prior to cell seeding. Mature intestinal organoids were washed with 436	  
PBS with 0.5 mM EDTA and dissociated in 0.5% Trypsin-EDTA. Trypsinization was 437	  
inactivated by FBS and clumps of cells removed using a 40 µm cell strainer. Cells were seeded 438	  
at 1.4 × 105 per well and grown in proliferation media 16. After 24 h, cells were maintained in 439	  
differentiation media 14 and differentiation allowed to occur for 5 days prior to infection. 440	  
Differentiation of monolayers was confirmed by qPCR measurement of stem cell marker 441	  
leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5), mature enterocyte marker 442	  
alkaline phosphatase (ALP), and epithelial cell marker villin transcripts at days 0, 3 and 5. 443	  
Relative fold changes were assessed with the 2−ΔΔCT method using the HPRT1 transcript for 444	  
normalization. 445	  
 446	  
Monolayers growing in 48-well plates were infected in triplicate at MOI 10 at 37 ºC for 1 h, 447	  
washed twice with serum-free media and overlaid with 250 µL of differentiation media. Aliquots 448	  
of media corresponding to half the volume were taken at indicated time points and clarified by 449	  
centrifugation at 6,000 g for 5 min. The lysed cell debris at 48 hpi was collected using 250 µL of 450	  
differentiation media. All collected samples were titrated on RD cell monolayers using plaque 451	  
assay as readout. The 48 hpi virus stocks were used for RNA isolation and RT-PCR analysis to 452	  
confirm the presence of the introduced mutations. 453	  
 454	  
Analysis of samples collected from infected human intestinal organoid monolayers 455	  
Samples collected at 36 and 48 hpi were used for EV7 RNA and VP3 quantification. The amount 456	  
of EV7 RNA was determined by quantitative reverse transcription-PCR (RT-qPCR). A 20 µl 457	  
aliquot of each sample was mixed with 4 × 106 plaque forming units (PFUs) of purified Sindbis 458	  
virus (SINV) stock, which was used for normalization and to control the quality of RNA 459	  
isolation. RNA was extracted using the Qiagen QIAamp viral RNA mini kit. Reverse 460	  
transcription was performed using the QuantiTect reverse transcription kit (Qiagen) using virus-461	  
specific reverse primers for SINV (GTTGAAGAATCCGCATTGCATGG) and EV7 462	  
(CACCGAATGCGGAGAATTTACC). EV7 and SINV-specific primers were used to quantify 463	  
corresponding virus RNAs; the primer efficiency was within 95–105%. Quantitative PCR was 464	  
performed in triplicate using SsoFast EvaGreen Supermix (Bio-Rad) in a ViiA 7 Real-time PCR 465	  
system (Applied Biosystems) for 40 cycles with two steps per cycle. Results were normalized to 466	  
the amount of SINV RNA in the same sample. Fold differences in RNA concentration were 467	  
calculated using the 2−ΔΔCT method. Protein analysis from the same samples was performed by 468	  
western blot using Enterovirus pan monoclonal antibody at 1:500 dilution. VP3-specific bands 469	  
were quantified using LI-COR imager software. EV7 titers were normalized by either the RNA 470	  
or protein quantities and further normalized to the mean value of the wt EV7 samples. The same 471	  
set of samples was subjected to treatment with Triton X-100 at final concentration 1% or PBS as 472	  
a control, titrated by plaque assay, and presented as the ratio of Triton X-100 treated to PBS-473	  
treated values. 474	  
 475	  
Membrane flotation assay of organoid-derived viruses 476	  
Differentiated human intestinal organoid cultures were infected with EV7 and mutants. At 36 477	  
hpi, media was collected, clarified by centrifugation at 6,000 g for 5 min, and aliquots were 478	  
titrated with or without Triton X-100 pre-treatment. EV7 derived from infected RD cells (MOI 479	  
1) collected at 20 hpi in serum-free media and clarified by centrifugation at 6,000 g for 5 min 480	  
was used as a control. Samples were then used for the flotation assay in an iodixanol gradient as 481	  
described by Vogt et al. 32 with minor modifications. Briefly, each sample was mixed with 1.5 ml 482	  
0.25 M sucrose in PBS and 1.5 ml iodixanol (Sigma) resulting in 30% iodixanol concentration. A 483	  
discontinuous iodixanol gradient consisting of 1 ml 60%, 3 ml 30% (containing the sample), 4 484	  
ml 20% and 4 ml 10% iodixanol was layered and spun at 200,000 g for 16 h at 4° C in a SW41Ti 485	  
rotor. A total of 15 fractions (∼800 µl each) were collected using a fractionator. Each fraction 486	  
was titrated by plaque assay on RD cells. The resulting titers were normalized to the total amount 487	  
of virus in each sample and plotted. 488	  
 489	  
Neutralization assays 490	  
Virus neutralization was performed by mixing virus sample corresponding to 50–500 PFUs (with 491	  
appropriate dilution for counting input PFUs) with 1:400 dilution of EV7 neutralization serum 492	  
(Batch nr. 2/69, The Standards Laboratory, Central Public Health Laboratory, London N.W.9., 493	  
UK), incubating the mixture at room temperature for 30 min, and then plating on monolayers of 494	  
RD cells for plaque formation. The neutralization assay via prevention of receptor-mediated 495	  
attachment was performed on monolayers of RD cells pretreated for 1 h with anti-DAF antibody 496	  
at 1:500 dilution (rabbit, in-house, sourced from David Evans, 33), followed by infection and 497	  
plaque formation. 498	  
 499	  
Fractionation analysis of UP 500	  
For the analysis of overexpressed UP, electroporation of HeLa cells was performed in full media 501	  
at 240 V and 975 µF using a BioRad Gene Pulser. At 20 h post-electroporation, cells were 502	  
washed with PBS and fractionated using a subcellular protein fractionation kit for cultured cells 503	  
(Thermo Scientific) according to the manufacturer’s instructions. Equal aliquots of whole cell 504	  
lysate, cytoplasmic and membrane fractions were analyzed by western blot using the indicated 505	  
virus- or cellular target-specific antibodies. 506	  
 507	  
Immunofluorescence microscopy 508	  
Differentiated human intestinal organoid monolayers were grown on IBIDI 8-well chamber 509	  
slides and at 5 days post differentiation infected with EV7 or mutants at MOI 10. For the analysis 510	  
of overexpressed UP, the transfection of HeLa cells was performed using Lipofectamine 2000. 511	  
For moderately expressed UP, a HeLa cell line stably expressing UP (HeLa-UP) was created 512	  
using the pCAG-UP construct as previously described 30. At 9 hpi or 20 hpt, cells were fixed 513	  
with 4% paraformaldehyde for 20 min at room temperature, followed by permeabilization with 514	  
PBS containing 0.5% Triton X-100 (for infected organoids), 0.1% Triton X-100 or 0.2% saponin 515	  
(for transfected HeLa cells and the HeLa-UP cell line) for 10 min. Cells were blocked in 5% goat 516	  
serum and incubated sequentially with primary (Enterovirus pan monoclonal antibody, Scions J2 517	  
anti-dsRNA IgG2a monoclonal antibody (Scicons, 10010500) or anti-calnexin antibody) and 518	  
secondary (Alexa Fluor 488- or Alexa Fluor 597-conjugated goat anti-mouse or goat anti-rabbit, 519	  
Thermo Fisher, A11001, A21441, A11032) antibodies. Nuclei were counter-stained with 520	  
Hoechst (Thermo Scientific). The images are a projection of a z-stack (Fig. S9) or single plane 521	  
image (Fig. 6b) taken with a Leica SP5 Confocal Microscope using a water-immersion 63× 522	  
objective. 523	  
 524	  
Ribosome profiling 525	  
RD cells were grown on 150-mm dishes to reach 90% confluency. Following previous 526	  
optimization of ribosome profiling during virus infection, we infected cells at a MOI of 20 with 527	  
EV7, PV1 or EV-A71 virus stocks. At indicated times postinfection, cells were treated with 3 528	  
mM cycloheximide for 3 min, flash frozen in a dry ice/ethanol bath, and lysed in the presence of 529	  
0.36 mM cycloheximide. Cell lysates were subjected to Ribo-Seq based on the previously 530	  
described protocols 11,34, except Ribo-Zero Gold rRNA removal kit (Illumina), not DSN, was 531	  
used to deplete ribosomal RNA. Amplicon libraries were deep sequenced using an Illumina 532	  
NextSeq platform. 533	  
 534	  
Computational analysis of Ribo-Seq data 535	  
Ribo-Seq analysis was performed as described previously 11. Adaptor sequences were trimmed 536	  
using the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit) and trimmed reads shorter 537	  
than 25 nt were discarded. Reads were mapped to host (Homo sapiens) and virus RNA using 538	  
bowtie version 1 35, with parameters -v 2 --best (i.e. maximum 2 mismatches, report best match). 539	  
Mapping was performed in the following order: host rRNA, virus RNA, host RefSeq mRNA, 540	  
host non-coding RNA, host genome. 541	  
 542	  
To normalize for library size, reads per million mapped reads (RPM) values were calculated 543	  
using the sum of total virus RNA plus host RefSeq mRNA reads (positive-sense reads only) as 544	  
the denominator. A +12 nt offset was applied to the RPF 5′ end positions to give the approximate 545	  
ribosomal P-site positions. To calculate the phasing and length distributions of host and virus 546	  
RPFs, only RPFs whose 5′ end (+12 nt offset) mapped between the 16th nucleotide 3′ of the 547	  
initiation codon and the 16th nucleotide 5′ of the termination codon of coding sequences (ppORF 548	  
for viruses; RefSeq mRNA coding regions for host) were counted, thus avoiding RPFs of 549	  
initiating or terminating ribosomes. Histograms of host RPF positions (5′ end +12 nt offset) 550	  
relative to initiation and termination codons were derived from reads mapping to RefSeq 551	  
mRNAs with annotated coding regions ≥450 nt in length and with annotated 5′ and 3′ UTRs ≥60 552	  
nt in length. 553	  
 554	  
Virus uORF and ppORF expression levels (reads per kilobase per million mapped reads; RPKM) 555	  
were calculated by counting RPFs whose 5′ end (+12 nt offset) mapped within the respective 556	  
coding region. The region of overlap between the uORF and ppORF was excluded. To mitigate 557	  
the effect of RPFs potentially deriving from translation of very short overlapping ORFs (Fig. 558	  
S4d, Fig. S5d and Fig. S6d), and given the high degree of triplet phasing in the data (Fig. S4c, 559	  
Fig. S5c and Fig. S6c), we only counted RPFs mapping in phase 0 with respect to the uORF or 560	  
ppORF, as appropriate; these values were then scaled by the ratio of total polyprotein-mapping 561	  
RPFs to phase-0 polyprotein-mapping RPFs (a value in the range 1.24–1.39, depending on the 562	  
library). Due to variability in RPF density as a result of variable codon dwell-times besides 563	  
biases introduced during library preparation, the short length of the uORF, and the possibility of 564	  
non-specific initiation in other very short ORFs between the uORF AUG and the ppORF AUG, it 565	  
was not possible to precisely calculate the relative translation efficiencies of uORF and ppORF 566	  
from the Ribo-Seq data.  567	  
 568	  
Comparative genomic analysis 569	  
Genus Enterovirus nucleotide sequences were downloaded from the National Center for 570	  
Biotechnology Information (NCBI) on 2 July 2017. The bona fide polyprotein AUG initiation 571	  
site was identified in each sequence by alignment to NCBI genus Enterovirus RefSeqs. 572	  
Sequences that contained the complete ppORF and at least 160 nt upstream were identified and 573	  
used for further analysis. Patent sequence records, sequences with NCBI keywords 574	  
“UNVERIFIED”, “STANDARD_DRAFT”, “VIRUS_LOW_COVERAGE” or 575	  
“VIRUS_AMBIGUITY”, and sequences with >10 ambiguous nucleotide codes (e.g. “N”s) 576	  
indicative of low quality or incomplete sequencing, were removed, leaving 3136 sequences. 577	  
 578	  
To define enterovirus clades, the following International Committee on Taxonomy of Viruses 579	  
(ICTV) type sequences for 13 genus Enterovirus species were used as reference sequences: 580	  
Enterovirus A – AY421760, Enterovirus B – M88483, Enterovirus C – V01149, Enterovirus D – 581	  
AY426531, Enterovirus E – D00214, Enterovirus F – DQ092770, Enterovirus G – AF363453, 582	  
Enterovirus H – AF326759, Enterovirus I – KP345887, Enterovirus J – AF326766, Rhinovirus A 583	  
– FJ445111, Rhinovirus B – DQ473485, and Rhinovirus C – EF077279. The 3136 sequences 584	  
were grouped into clades according to with which reference sequence they shared greatest 585	  
polyprotein amino acid identity. Only three sequences – namely KU587555, KX156158 and 586	  
KX156159 – had <65% amino acid identity to any of the 13 reference sequences and these 587	  
sequences were left unclustered (Fig. 1b). For the sake of simplicity, recombination – a fairly 588	  
common occurrence within enterovirus species 36 – was ignored. The phylogenetic tree (Fig. 1b) 589	  
was constructed using polyprotein amino acid sequences aligned with MUSCLE 37 and processed 590	  
with Gblocks 38 using default parameters to remove poorly aligned regions (resulting in a 591	  
reduction from 2461 alignment columns to 1693 alignment columns). A maximum likelihood 592	  
phylogenetic tree was estimated using the Bayesian Markov chain Monte Carlo method 593	  
implemented in MrBayes version 3.2.3 39 sampling across the default set of fixed amino acid rate 594	  
matrices, with 100,000 generations, discarding the first 25% as burn-in (other parameters were 595	  
left at defaults). The tree was visualized with FigTree (http://tree.bio.ed.ac.uk/software/figtree/).  596	  
 597	  
In each of the 3136 sequences, the AUG codon in dVI of the IRES was identified based on the 598	  
conserved sequences surrounding it (typically UU AUG GU[C/G]ACA, or slight variations 599	  
thereof; dVI AUG in bold). Sequences were defined as having the uORF if the ORF beginning 600	  
with this AUG codon and including the first in-frame stop codon (a) overlapped the ppORF by at 601	  
least 1 nt, (b) was not in-frame with the ppORF, and (c) contained at least 150 nt upstream of the 602	  
polyprotein AUG codon. 603	  
 604	  
The ratios of nonsynonymous to synonymous substitution rates (dN/dS) were estimated using the 605	  
codeml program in the PAML package 10. To do this in an acceptable computational time, the 606	  
alignments were reduced to fewer sequences by applying BLASTCLUST (a single-linkage 607	  
BLAST-based clustering algorithm) 40. First, within each clade, for those sequences containing a 608	  
uORF according to the above definition, the uORF nucleotide sequences (3′-truncated, after a 609	  
whole number of codons, to exclude the part overlapping the ppORF) were extracted, clustered 610	  
with BLASTCLUST (-p F -L 0.95 -b T -S 95, i.e. 95% coverage, >95% nucleotide identity 611	  
threshold) and, within each BLASTCLUST cluster, a single representative sequence was 612	  
retained. In order to mitigate the effect of potential sequencing errors, in each cluster the 613	  
representative sequence was chosen to be the sequence with the most identical copies (with ties 614	  
broken arbitrarily), or, if there were no duplicated uORF sequences, the sequence closest to the 615	  
centroid (minimum summed pairwise nucleotide distances from sequence i to all other sequences 616	  
j within the cluster). This reduced the uORF sequence sets for enterovirus clades A, B, C, E, F 617	  
and G from 1182, 357, 345, 9, 11 and 16 to 53, 177, 81, 8, 10 and 13 sequences, respectively. In 618	  
each clade, the remaining nucleotide sequences were translated, aligned as amino acids with 619	  
MUSCLE, and the amino acid alignment used to guide a codon-based nucleotide alignment 620	  
(EMBOSS tranalign) 41. Alignment columns with gap characters in any sequence were removed, 621	  
resulting in a reduction from 53, 52, 54, 51, 51 and 69 to 50, 50, 50, 50, 51 and 44 codon 622	  
positions in enterovirus clades A, B, C, E, F and G, respectively. PhyML 42 was used to produce 623	  
a nucleotide phylogenetic tree for each of these sequence alignments. Using these tree 624	  
topologies, dN/dS was calculated for each alignment with codeml. Standard deviations for the 625	  
codeml dN/dS values were estimated via a bootstrapping procedure, in which codon columns of 626	  
the alignment were randomly resampled (with replacement); for each clade, 100 randomized 627	  
alignments were generated, and their dN/dS values calculated with codeml. 628	  
 629	  
For sequences containing the uORF, coding potential within each reading frame was analyzed 630	  
using MLOGD 9. First, within each clade, for those sequences containing a uORF according to 631	  
the above definition, the polyprotein amino acid sequences were determined, clustered with 632	  
BLASTCLUST (-p T -L 0.95 -b T -S 99, i.e. 95% coverage, >99% amino acid identity threshold) 633	  
and, within each BLASTCLUST cluster, a single representative sequence was retained using the 634	  
same procedure as described above for uORF nucleotide sequences but using the polyprotein 635	  
amino acid sequences. The ICTV reference sequences (as per Fig. 1b) were also retained as 636	  
reference sequences for the Enterovirus E, F and G clades, whereas EV-A71, EV7 and PV1 were 637	  
appended and used as the reference sequences for, respectively, the Enterovirus A, B and C 638	  
clades. This reduced the sequence sets for enterovirus clades A, B, C, E, F and G to 89, 220, 101, 639	  
8, 10 and 15 sequences, respectively. For each clade, the remaining polyprotein amino acid 640	  
sequences were aligned with MUSCLE, processed with Gblocks as described above, and 641	  
analyzed with PhyML to produce the tree topology for the MLOGD analysis. Then, for each 642	  
clade, each individual genome sequence was aligned to the reference sequence using code2aln 643	  
version 1.2 43, and mapped to reference sequence coordinates by removing alignment positions 644	  
that contained a gap character in the reference sequence. These pairwise alignments were 645	  
combined to give whole-clade alignments which were analyzed with MLOGD using a 40-codon 646	  
sliding window and a 1-codon step size. For each of the three reading frames, within each 647	  
window the null model is that the sequence is non-coding whereas the alternative model is that 648	  
the sequence is coding in the given reading frame. Positive/negative values indicate that the 649	  
sequences in the alignment are likely/unlikely to be coding in the given reading frame (Fig. 1d 650	  
and Fig. S1b). 651	  
 652	  
For the analysis of non-enterovirus taxa within the Picornaviridae family (Fig. S14a–S23a), 653	  
coding potential within each reading frame was analysed using MLOGD 9 and synonymous site 654	  
conservation was analysed with SYNPLOT2 44. For these analyses we generated codon-655	  
respecting alignments of full-genome sequences using a procedure described previously 44. In 656	  
brief, each individual genome sequence was aligned to a reference sequence using code2aln 657	  
version 1.2 43. Genomes were then mapped to reference sequence coordinates by removing 658	  
alignment positions that contained a gap character in the reference sequence, and these pairwise 659	  
alignments were combined to give the multiple sequence alignment. These were analysed with 660	  
MLOGD (see above) using a 40-codon sliding window and a 5-codon step size. To assess 661	  
conservation at synonymous sites, the polyprotein coding region and any non-overlapping 662	  
portion of the additional ORF sequence were extracted from the alignment, the polyprotein and 663	  
additional ORF sequences were concatenated in-frame (where relevant), and the alignment 664	  
analysed with SYNPLOT2 using a 25-codon sliding window. Amino acid alignments of the 665	  
complete putative new proteins (Fig. S14b–S23b) were performed with MUSCLE 37. 666	  
 667	  
Transmembrane (TM) domains were predicted with Phobius (EMBL-EBI) 45. 668	  
	  669	  
Statistics	  and	  Reproducibility	  670	  
All t-tests are two-tailed and assume separate variances for the two populations being compared. 671	  
Raw data for the organoid experiments and details of the t-tests performed are reported in Table 672	  
S3. Raw data for the dual luciferase assays are reported in Table S4.	  673	  
 674	  
Data	  Availability	  675	  
The sequencing data reported in this paper have been deposited in ArrayExpress 676	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 810	  
Fig. 1. Comparative genomic analysis of the Enterovirus genus. a, Schematic representation 811	  
of the enterovirus genome showing the uORF (green), ppORF (blue), and 5ʹ/3ʹ UTR RNA 812	  
structures (not to scale). b, Phylogenetic tree for the Enterovirus genus. Within each clade, the 813	  
number of sequences containing (pink) or not containing (orange) the uORF, and the percentage 814	  
of sequences containing the uORF are indicated. The tree, calculated with MrBayes, is based on 815	  
the polyprotein amino acid sequences of the indicated reference sequences, and is midpoint-816	  
rooted; nodes are labelled with posterior probability values. c, Box plots of distances between the 817	  
dVI AUG codon and the polyprotein AUG codon for different enterovirus clades (centre lines = 818	  
medians; boxes = interquartile ranges; whiskers extend to most extreme data point within 1.5 × 819	  
interquartile range from the box; circles = outliers; n = sum of sequences with and without the 820	  
uORF as shown in (a)). In each clade, the percentage of sequences that contain the uORF is 821	  
indicated. d, Coding potential in the three reading frames (indicated by the three colors) as 822	  
measured with MLOGD, for sequences that contain the uORF (see Fig. S1b for Enterovirus E, F 823	  
and G). Positive scores indicate that the sequence is likely to be coding in the given reading 824	  
frame. Reading frame colors correspond to the genome maps shown above each plot, indicating 825	  
the ppORF and uORF in the reference sequences EV-A71, EV7 and PV1, respectively. 826	  
 827	  
 828	  
 829	  
 830	  
  831	  
 832	  
Fig 2. Analysis of wt and mutant EV7 viruses. a, Schematic representation of the EV7 IRES 833	  
dVI and uORF region with the uORF start and stop (green) and main ORF start (blue) annotated. 834	  
The UP amino acid sequence is shown in the shadowed inset with the predicted TM domain 835	  
underlined. b, Predicted UP amino acid sequences for the wt and mutant EV7 viruses. c, The 836	  
infectivity of in vitro-synthesized viral RNAs (in PFUs per 1 µg T7 RNA), the titers of the 837	  
viruses after transfection (P0) and one passage in RD cells (P1), the comparative plaque sizes 838	  
(see also Fig. S3a), RT-PCR analysis of viral RNA isolated after three passages in RD cells, and 839	  
the results of the competition assay (see also Fig. S3b). d, Analysis of relative IRES activities by 840	  
dual-luciferase reporter assay in HEK293T cells. Schematic representation of the modified 841	  
pSGDluc expression vector to measure initiation at the polyprotein AUG (left). Relative IRES 842	  
activities normalized to cap-dependent signal and wt EV7 IRES activity (means ± s.d.; n = 3 843	  
biologically independent experiments) (right). 844	  
  845	  
 846	  
Fig. 3. Timecourse of UP expression in EV7-infected cells. a, Analysis of viral protein 847	  
expression in RD cells infected with wt or mutant EV7 viruses. Cells were infected at an MOI of 848	  
50, harvested at 0–8 hpi as indicated, and accumulation of UP and virus structural protein VP3 849	  
was analyzed by western blotting with anti-UP and anti-VP3 antibodies. UP transiently 850	  
expressed from a pCAG promoter in HeLa cells taken at 20 h post-transfection was used as a UP 851	  
size control. b, Analysis of viral protein expression in RD cells infected with wt or mutant Strep-852	  
tagged EV7 viruses. Cells were infected at an MOI of 50, harvested at 0–8 hpi as indicated, and 853	  
accumulation of Strep-tagged UP (StrUP) and VP3 was analyzed by western blotting with anti-854	  
Strep and anti-VP3 antibodies. StrUP transiently expressed from a pCAG promoter in HeLa cells 855	  
taken at 20 h post-transfection was used as a StrUP size control. The experiments in (a-b) were 856	  
independently repeated three times with similar results. c, One-step growth curves of rescued 857	  
viruses. RD cells were infected with P1 stocks of wt or mutant viruses at an MOI of 1. Aliquots 858	  
of the culture media were collected at 0, 3, 6, 9, 12 and 24 hpi, and the viral titer in the aliquots 859	  
was analyzed via plaque assay on RD cells. The results of one out of two replicates are shown 860	  
(see Fig. S10 for the repeat). d, Ribosome profiling of EV7-infected cells at 4 and 6 hpi. Ribo-861	  
Seq RPF densities in reads per million mapped reads (RPM) are shown with colors indicating the 862	  
three phases relative to the main ORF (blue – phase 0, green – phase +1, orange – phase +2), 863	  
each smoothed with a 3-codon sliding window. e, Mean ribosome density in the EV7 uORF and 864	  
main ORF at 4 and 6 hpi, based on the in-phase Ribo-Seq density in each ORF (excluding the 865	  
overlapping region; RPKM = reads per kilobase per million mapped reads). 866	  
  867	  
 868	  
 869	  
Fig. 4. Translation of the uORF in poliovirus PV1 and enterovirus EV-A71. a, Schematic 870	  
representation of the PV1 IRES dVI and uORF region with the uORF start and stop (orange) and 871	  
main ORF start (blue) annotated. The UP amino acid sequence is shown in the shadowed inset 872	  
with the predicted TM domain underlined. b, Ribosome profiling of PV1-infected cells at 4 and 873	  
6 hpi. Ribo-Seq RPF densities in reads per million mapped reads (RPM) are shown with colors 874	  
indicating the three phases relative to the main ORF (blue – phase 0, green – phase +1, orange – 875	  
phase +2), each smoothed with a 3-codon sliding window (see Fig. S12a for repeats). c, Mean 876	  
ribosome density in the PV1 uORF and main ORF at 4 and 6 hpi, based on the in-phase Ribo-877	  
Seq density in each ORF (excluding the overlapping region; RPKM = reads per kilobase per 878	  
million mapped reads). d, Analysis of viral protein expression in RD cells infected with wt or 879	  
HA-tagged PV1 viruses. Cells were infected at an MOI of 50, harvested at 9 and 11 hpi, and 880	  
accumulation of HA-tagged UP (HA-UP) and virus structural protein VP3 was analyzed by 881	  
western blotting with anti-HA, anti-VP3 and anti-tubulin antibodies. HA-UP transiently 882	  
expressed from a pCAG promoter in HeLa cells taken at 20 h post-transfection was used as a 883	  
HA-UP size control. e, Schematic representation of the EV-A71 IRES dVI and uORF region 884	  
with the uORF start and stop (orange) and main ORF start (blue) annotated. The UP amino acid 885	  
sequence is shown in the shadowed inset with the predicted TM domain underlined. f, Analysis 886	  
of protein expression in RD cells infected with enteroviruses EV-A71, EV7 or PV1. Cells were 887	  
infected at an MOI of 20, harvested at 0–8 hpi as indicated, and expression of virus and host 888	  
proteins was analyzed by western blotting with anti-VP3 and GAPDH antibodies. The 889	  
experiments in (d,f) were independently repeated three times with similar results. g, Ribosome 890	  
profiling of EV-A71-infected cells at 5 and 7.5 hpi (see Fig. S12b for repeats). h, Mean ribosome 891	  
density in the EV-A71 uORF and main ORF at 5 and 7.5 hpi. 892	  
 893	  
 894	  
 895	  
Fig. 5. Analysis of EV7 infection in differentiated human intestinal organoids. a, Schematic 896	  
representation of production of differentiated intestinal organoids. Crypts are isolated from the 897	  
terminal ileum intestinal region of patients and grown as undifferentiated organoid cultures 898	  
(lower image, scale bar 100 µm). After differentiation, the organoids are split into monolayers 899	  
and grown for 5 days in the presence of growth factors (upper image, scale bar 50 µm). b, 900	  
Monolayers of differentiated organoid cultures were infected in triplicate with P1 stocks of wt or 901	  
mutant viruses at MOI 10, washed twice, aliquots of culture media were collected at 0, 3, 6, 9, 12 902	  
and 24 hpi, and viral titer was analyzed via plaque assay on RD cells. The experiment was 903	  
repeated for organoid cultures originating from two different patients (left and right graphs; 904	  
means ± s.d.; *, ** p = 0.052, 0.00089 at 36 hpi and 0.0012, 0.046 at 48 hpi for patients 1 and 2 905	  
respectively). c, Representative confocal images of mock-infected and infected (EV7, EV7-PTC 906	  
and EV7-Loop) organoid monolayers at 9 hpi, stained for enterovirus structural protein (VP3, 907	  
green) or dsRNA (green), and nuclei (Hoechst, blue). Scale bar 50 µm. d, Representative images 908	  
of mock-infected and infected (EV7, EV7-PTC and EV7-Loop) organoid monolayers at 9 and 24 909	  
hpi. Scale bar 50 µm. e, Virus titers normalized by virus protein (blue) or virus RNA (red) for 910	  
infected differentiated organoid cultures at 36 and 48 hpi. f, Fold differences in virus titers after 911	  
Triton X-100 treatment of clarified supernatants derived from infected differentiated organoid 912	  
cultures. g, Fold differences in virus titers after Triton X-100 treatment of lysed cells from 913	  
infected differentiated organoid cultures at 48 hpi. h, Membrane flotation assay. At 36 hpi, 914	  
clarified supernatants from infected differentiated organoid cultures were spun in a 60-30-20-915	  
10% iodixanol gradient. Fifteen fractions were collected and virus titers determined on RD cells. 916	  
Virus derived from infected RD cells was used as a control (green line). The density traces are 917	  
shown in grey. Data represent two (c,d) or three (b,e-g) biologically independent experiments. In 918	  
(b,e-g), p-values come from comparing the six mutant with three wt values in each group (two-919	  
tailed t-tests). See Table S3 for raw data (b,e-h). 920	  
  921	  
 922	  
 923	  
Fig. 6. Membrane association of UP and temporal analysis of uORF translation. a, Fraction 924	  
of non-neutralized EV7 in RD cell-derived virus and membrane fractions of flotated organoid-925	  
derived virus (from Fig. 5h). The membrane fractions for each flotated sample were assayed 926	  
using (i) virus mixed with EV7 neutralization serum (left panel), (ii) cells pre-incubated with 927	  
anti-DAF antibody (middle panel), and (iii) both methods simultaneously (right panel) (means ± 928	  
s.d.; n = 4 biologically independent experiments; p-values come from comparing the 12 929	  
organoid-derived samples with the four RD cell-derived samples using two-tailed t-tests). See 930	  
Table S3 for raw data. b, Representative confocal images of HeLa cells transfected with pCAG-931	  
UP, and the HeLa-UP cell line, stained for UP (green), ER (Calnexin, red) and nuclei (Hoechst, 932	  
blue). The images are averaged single plane scans. Scale bar 10 µm. See Fig. S9 for lower 933	  
magnification and pCAG control images. c, Fractionation analysis of HeLa cells. Cells were 934	  
electroporated with pCAG-UP, fractionated, and whole cell lysate (WCL) and cytoplasmic 935	  
(Cyto) and membrane (Mem) fractions analyzed by immunoblotting with antibodies to UP, 936	  
tubulin, VDAC or calnexin as indicated. The experiments in (b-c) were independently repeated 937	  
three times with similar results. d, Schematic of the modified pSGDluc expression vectors used 938	  
to measure initiation at the polyprotein (ppORF, in blue) and upstream (uORF, in green) AUG 939	  
codons. e, Analysis by dual-luciferase reporter assay in HeLa cells of relative IRES activities for 940	  
ppORF and uORF expression, with and without T7-transcribed infectious EV7 RNA (infected 941	  
and not infected, respectively). IRES activities were normalized to cap-dependent signal and 942	  
presented as the ratio ppORF/uORF activity (means ± s.d.). n = 6 biologically independent 943	  
experiments. Titers from the infected samples measured by plaque assay in RD cells are plotted 944	  
on a log scale (dotted pink line). f, IRES activities for ppORF and uORF expression relative to 945	  
cap-dependent expression (i.e. FFLuc/RLuc), with and without co-transfection of T7-transcribed 946	  
infectious RNA. See Table S4 for raw data (e-f). 947	  
 948	  
